PERRIGO Co plc 8-K

What Happened

• Perrigo Co. plc (PRGO) announced fourth‑quarter results for the period ended December 31, 2025 in a press release dated February 26, 2026 (Exhibit 99.1 to the 8‑K). The company furnished supplemental non‑GAAP financial measures and described how those measures are calculated and used by management.

Key Details

• Report filed: Form 8‑K furnished on February 26, 2026 covering results for the quarter ended December 31, 2025; press release attached as Exhibit 99.1.
• Non‑GAAP measures provided: adjusted gross profit, adjusted net income, adjusted operating income, adjusted diluted EPS, adjusted gross/operating margin, constant‑currency net sales, adjusted EBITDA and others.
• CORE metrics: Perrigo also reports "CORE" measures (CORE net sales, CORE organic net sales, CORE net income, CORE margins) that exclude infant formula (under strategic review) and certain divestitures to show ongoing operations.
• Typical adjustments listed: amortization of acquired intangibles, unusual litigation, restructuring and termination benefits, impairment charges, gains/losses on divestitures/brand sales, infant formula remediation, non‑GAAP tax adjustments, foreign currency translation effects.
• Outlook note: Perrigo says it cannot reasonably reconcile certain FY2026 non‑GAAP outlook items (e.g., adjusted margins, adjusted EPS, adjusted EBITDA, net leverage) to GAAP because of unpredictable items like non‑recurring infant formula charges, timing/amount of restructuring, and related tax effects.
• Disclosure status: Information in the 8‑K is furnished (not “filed”) and not subject to Section 18 liabilities; not automatically incorporated by reference into other filings.

Why It Matters

• Investors get a fuller picture: Perrigo is providing both GAAP results and a broad set of non‑GAAP and CORE metrics that management uses for internal planning and compensation. Those adjusted figures can help investors compare operating trends period‑to‑period and to peers, but they exclude recurring items such as amortization and specific one‑offs (e.g., infant formula remediation).
• Caution on forward guidance: Because Perrigo cannot reconcile some FY2026 non‑GAAP outlook items to GAAP due to uncertain, potentially material items, investors should treat forward‑looking non‑GAAP figures with care and review the GAAP statements alongside the adjusted measures.